Tag: Virtual ACC
Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro
According to recently presented TICO trial data, a press release reports, patients with acute co...
Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement
According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei Univ...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardi...
Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease
The longest follow-up to date of patients with left main coronary artery disease (LMCAD) has fou...
Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version
Today at the American College of Cardiology/World Congress of Cardiology’s virtual scientific se...
Virtual ACC: Use of radial artery in heart bypass surgery improves patient outcomes
Using the radial artery instead of the saphenous vein for patients undergoing coronary artery by...
Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolu...
Virtual ACC: Clopidogrel exposure along with aspirin and rivaroxaban should be “minimised or avoided” in PAD revascularisation
“More bleeding with background clopidogrel, even if not severe by adjudication, may be associate...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low ris...
Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO...
Virtual ACC: Antiplatelet drugs increase risk for TAVI patients with atrial fibrillation
In the POPULAR TAVI trial, patients with atrial fibrillation who took oral anticoagulants alone ...
Virtual ACC: Low-dose colchicine after myocardial infarction is “economically dominant”
During the first Featured Clinical Research session of the virtual American College of Cardiolog...
Virtual ACC: Combining aspirin with rivaroxaban provides greater absolute risk reduction in diabetes
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative...
Virtual ACC: Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularisation
Treatment with aspirin plus rivaroxaban following lower extremity revascularisation in patients ...
Virtual ACC: Genotype-guided therapy after PCI does not hit study target
Today, during the Virtual American College of Cardiology (ACC) event (28–30 March, Central Time)...
